← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Dnatrix, Inc.
Carlsbad, CA
$3,013,200
Total funding
3
Grants
Funding over time
peak $852.6K · FY2014–22$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
FDA$2,000,000 · 1
NIH$1,013,200 · 2
By mechanism
R01$2,000,000 · 1
R44$852,568 · 1
R41$160,632 · 1
Investigators at Dnatrix, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Phase 1 Study of DNX-2440 for Resectable Colorectal Liver Metastasis - IND 018569$852,568
R44 · FY2022 · CA
Ph2a Study of DNX-2401 for Treatment of Glioblastoma (GBM) IND13,678 (12/23/2014)$500,000
R01 · FY2017 · FD
Ph2a Study of DNX-2401 for Treatment of Glioblastoma (GBM) IND13,678 (12/23/2014)$500,000
R01 · FY2016 · FD
Ph2a Study of DNX-2401 for Treatment of Glioblastoma (GBM) IND13,678 (12/23/2014)$500,000
R01 · FY2018 · FD
Ph2a Study of DNX-2401 for Treatment of Glioblastoma (GBM) IND13,678 (12/23/2014)$500,000
R01 · FY2019 · FD
Ex vivo purging strategy for treatment of multiple myeloma$160,632
R41 · FY2014 · CA